Rodríguez Portales J A, Arteaga E, López Moreno J M, Biglieri E G
Departamento de Endocrinología, Metabolismo y Nutrición, Escuela de Medicina, P. Universidad Católica de Chile, Santiago.
J Clin Endocrinol Metab. 1988 Feb;66(2):349-54. doi: 10.1210/jcem-66-2-349.
The function of the adrenal zona glomerulosa was studied in two pubertal siblings with the hypertensive virilizing form of congenital adrenal hyperplasia who had never been treated. Initially, their plasma 11-deoxycortisol and 11-deoxycorticosterone (DOC) levels were very high, PRA was suppressed, and plasma aldosterone and 18-hydroxycorticosterone (18-OHB) were undetectable. To selectively study zona glomerulosa function, the patients and five normal subjects were given dexamethasone (2 mg/day; thus suppressing zona fasciculata function), and their sodium intake was restricted to 10 mmol/day. After 3-5 days, the zona glomerulosa was stimulated with either angiotensin II or potassium chloride. The same protocol was repeated in the patients at various intervals up to 39 months after beginning maintenance therapy with dexamethasone (0.25 mg twice daily). PRA, plasma aldosterone, and 18-OHB remained low during the first 6 months of treatment. After the first year, PRA recovered, and the zona glomerulosa began to respond. Plasma aldosterone and 18-OHB levels reached normal basal and stimulated values in one of the patients after 2 yr of treatment, but remained subnormal after 39 months of treatment in the other patient. Both patients, however, had persistently elevated plasma DOC concentrations, suggesting slight but definite impairment of 11 beta-hydroxylation in the zona glomerulosa. We conclude that in spite of a severe and persistent 11 beta-/18-hydroxylation deficiency in the zona fasciculata, the zona glomerulosa can recover almost completely after prolonged treatment. Appropriate stimulation, however, discloses a minor 11 beta-hydroxylation impairment also in the zona glomerulosa. In addition, the lack of parallelism in zona glomerulosa 11 beta- and 18-hydroxylation of DOC provides evidence for the concept of different 18-hydroxylating systems in the adrenal cortex.
对两名青春期患有未接受过治疗的高血压性男性化型先天性肾上腺增生的同胞进行了肾上腺球状带功能研究。最初,他们的血浆11-脱氧皮质醇和11-脱氧皮质酮(DOC)水平非常高,血浆肾素活性(PRA)受到抑制,血浆醛固酮和18-羟皮质酮(18-OHB)无法检测到。为了选择性研究球状带功能,给这些患者和五名正常受试者服用地塞米松(2毫克/天,从而抑制束状带功能),并将他们的钠摄入量限制在10毫摩尔/天。3-5天后,用血管紧张素II或氯化钾刺激球状带。在用0.25毫克地塞米松每日两次开始维持治疗后的不同时间间隔(最长39个月),对患者重复相同方案。在治疗的前6个月,PRA、血浆醛固酮和18-OHB仍然较低。第一年之后,PRA恢复,球状带开始有反应。一名患者在治疗2年后,血浆醛固酮和18-OHB水平达到正常基础值和刺激值,但另一名患者在治疗39个月后仍低于正常水平。然而,两名患者的血浆DOC浓度持续升高,提示球状带中11β-羟化存在轻微但明确的损害。我们得出结论,尽管束状带存在严重且持续的11β/−18-羟化缺陷,但长期治疗后球状带几乎可以完全恢复。然而,适当刺激也揭示了球状带中存在轻微的11β-羟化损害。此外,球状带中DOC的11β-和18-羟化缺乏平行性,为肾上腺皮质中不同18-羟化系统的概念提供了证据。